News

Five year results from the world's longest-running clinical trial of paediatric contact lens wear has shown CooperVision's MiSight 1 Day...

Melbourne-based biotech company Opthea has demonstrated that combination therapy involving its lead drug candidate OPT-302 is superior to standalone Lucentis...

Specsavers Australia and New Zealand optometry director Mr Peter Larsen, who was influential in the optical chain's introduction to the...

Australia's consumer law watchdog is prosecuting online healthcare booking service HealthEngine. The company is accused of misleading and deceptive conduct...

A new intravitreal corticosteroid implant for diabetic macular oedema (DME) has withstood complex regulatory processes to secure approval in Australia....

The term essential indicates that its cause is unknown, but fatigue, stress or irritants are all possible contributing factors. It’s...

The race to develop eyewear technology for mainstream consumers has been one fraught with risk and failure.Even giants such as...

The decision paves the way for Italy’s national health syst to continue reimbursent for use of the Avastin (bevacizumab) in...

Tetrahydrocannabinol (THC), the drug’s primary psychoactive ingredient, was found to effectively reduce intraocular pressure (IOP) in the short term, particularly...

By blocking a ‘domino effect’ that causes the cancerous cells to multiply, researchers from Johns Hopkins University believe there is...